AVANT and Celldex in Reverse Merger
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 90 (Table of Contents)
Published: 7 Dec-2007
DOI: 10.3833/pdr.v2007.i90.256 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
AVANT immunotherapeutics and Celldex Therapeutics entered into merger agreement to form a new company to focus on the areas of oncology, infectious and inflammatory diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018